Barbara Collins

Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study

Vassiliki A. Papadimitrakopoulou, Yi‐Long Wu, J. Y. Han et al. · Annals of Oncology · 2018 · 250 citations

Egfr T790m, Sclerostin, Bone Morphogenic Protein +6

Acoustic neuromas following childhood radiation treatment for benign conditions of the head and neck

Arthur B. Schneider, Elaine Ron, Jay H. Lubin et al. · Neuro-Oncology · 2007 · 47 citations · Full text

Acoustic Neuroma Incidence, Engineering, Neurotology +20

The feasibility of early pulmonary rehabilitation and activity after COPD exacerbations: external pilot randomised controlled trial, qualitative case study and exploratory economic evaluation

Matthew Cox, Catherine O’Connor, Katie Biggs et al. · Health Technology Assessment · 2018 · 33 citations · Full text

Early clearance of plasma EGFR mutations as a predictor of response to osimertinib in the AURA3 trial.

Frances A. Shepherd, Vassiliki A. Papadimitrakopoulou, Tony Mok et al. · Journal of Clinical Oncology · 2018 · 32 citations

Aura3 Trial, Genetic Epidemiology, Immunology +18

Ultrasound-Detected Thyroid Nodules in Radiation-Exposed Patients: Changes Over Time

Dan Mihailescu, Barbara Collins, Andrew C. Wilbur et al. · Thyroid · 2005 · 22 citations